PRESTIGE BIOTECH Trademark

Trademark Overview


On Monday, November 8, 2021, a trademark application was filed for PRESTIGE BIOTECH with the United States Patent and Trademark Office. The USPTO has given the PRESTIGE BIOTECH trademark a serial number of 97114161. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, April 1, 2023. This trademark is owned by Prestige Biotech. The PRESTIGE BIOTECH trademark is filed in the Medical Instrument Products category with the following description:

Alcohol breath testing units; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Medical devices for use in treating or diagnosing pregnancy; Medical diagnostic apparatus for testing pregnancy, fertility's, infectious disease, sexually transmitted disease, tropical disease, tumor marker, drugs of abuse, alcohol saliva, chemical analysis, cardiac marker, chemical analysis, cardiac marker' Medical test kits for diabetes monitoring for home use' Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Home urine collection kit consisting of tubes, pipette, and self-mailer used to determine a person's nutraceutical needs; Medical test kits for diabetes monitoring for home use; Medical apparatus and instruments, namely, handheld ultrasound unit for cardiac diagnosis, screening and cardiovascular patient follow-up; Medical devices, namely, tubing and valve assembly set and electromechanical fluidic inst...
prestige biotech

General Information


Serial Number97114161
Word MarkPRESTIGE BIOTECH
Filing DateMonday, November 8, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, April 1, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAlcohol breath testing units; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Medical devices for use in treating or diagnosing pregnancy; Medical diagnostic apparatus for testing pregnancy, fertility's, infectious disease, sexually transmitted disease, tropical disease, tumor marker, drugs of abuse, alcohol saliva, chemical analysis, cardiac marker, chemical analysis, cardiac marker' Medical test kits for diabetes monitoring for home use' Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Home urine collection kit consisting of tubes, pipette, and self-mailer used to determine a person's nutraceutical needs; Medical test kits for diabetes monitoring for home use; Medical apparatus and instruments, namely, handheld ultrasound unit for cardiac diagnosis, screening and cardiovascular patient follow-up; Medical devices, namely, tubing and valve assembly set and electromechanical fluidic instrument, and other similar or related devices, which process human whole blood for the purpose of separating human components for use in blood transfusions and washing human red blood cells with clinical medical reagents for use in blood transfusions

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, November 17, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePrestige Biotech
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLas Vegas, NV 89103

Trademark Events


Event DateEvent Description
Monday, April 3, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, April 1, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Saturday, April 1, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, August 23, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 23, 2022NON-FINAL ACTION E-MAILED
Tuesday, August 23, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 17, 2022ASSIGNED TO EXAMINER
Monday, January 3, 2022TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, January 3, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, November 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 11, 2021NEW APPLICATION ENTERED